Genmab A (GMAB) Current Assets (2018 - 2026)

Genmab A (GMAB) has reported Current Assets for 9 consecutive years, with $2.8 billion the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Current Assets fell 28.36% year-over-year to $2.8 billion; the trailing twelve-month figure through Jun 2026 stood at $2.8 billion (down 28.36% YoY), and the FY2025 full-year result was $2.9 billion, down 26.03% from the prior year.
• Current Assets rose to $2.8 billion in Q2 2026 per GMAB's latest filing, from $2.6 billion in the prior quarter.
• Across five years, Current Assets topped out at $4.0 billion in Q1 2023 and bottomed at $691.9 million in Q3 2025.
• Historically, Current Assets has averaged $2.8 billion across 5 years, with a median of $2.7 billion in 2022.
• The widest YoY moves for Current Assets: up 90.39% in 2025, down 69.59% in 2025.
• Over 5 years, Current Assets stood at $2.5 billion in 2022, then gained by 22.94% to $3.1 billion in 2023, then decreased by 16.75% to $2.6 billion in 2024, then gained by 11.32% to $2.9 billion in 2025, then retreated by 2.91% to $2.8 billion in 2026.
• According to Business Quant data, Current Assets over the past three periods registered $2.8 billion, $2.6 billion, and $2.9 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.